BE
BE · BE · BE-AMP-SAM662049-00
Orserdu 345 mg
ATC L02BA04
Last synced from FAMHP / AFMPS (Belgium) on
Identification
ManufacturerStemline Therapeutics
CountryBE (BE)
ATC codeL02BA04
Dispensing—
ReimbursedNo
SourceFAMHP / AFMPS (Belgium)
Last synced6/13/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Orserdu 345 mg",
"name_fr": "Orserdu 345 mg",
"name_nl": "Orserdu 345 mg",
"amp_code": "SAM662049-00",
"strengths": [
"345.0000",
"345.0000"
],
"pack_count": 1,
"substances": [
"Elacestrant Dihydrochloride",
"Elacestrant"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Elacestrant",
"authorisation_numbers": [
"EU/1/23/1757/002"
]
}Related drugs
Other records sharing ATC code L02BA04.
- GBKorserdu 345mg tabletsMenarini Stemline UK Ltd
- GBKorserdu 86mg tabletsMenarini Stemline UK Ltd
- 🇨🇭OrserduStemline Therapeutics Switzerland GmbH
- 🇨🇭OrserduStemline Therapeutics Switzerland GmbH
- PLOrserduStemline Therapeutics B.V.
- PLOrserduStemline Therapeutics B.V.
- ISOrserduStemline Therapeutics B.V.
- ISOrserduStemline Therapeutics B.V.
Access this data programmatically
Query Orserdu 345 mg and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.